Myelofibrosis (MF) is a chronic, BCR::ABL–negative myeloproliferative neoplasm (MPN) that is characterized by changes in blood counts, splenomegaly, disease-associated symptoms, and bone marrow (BM) fibrosis. Here, BCR is linked to myeloproliferative neoplasm.